Flückiger F. A., Hanbury D. Pharmacographia: a history of the principle drugs of vegetable origin, met with in Great Britain and British India. London: MacMillan and Co.; 1874:302-31.

Guerra F. The introduction of Cinchona in the treatment of malaria, parts 1 and 2. J. Trop. Med. Hyg. 1977;80(6):112-8;135-40.

Yalcindag E., Elguero E., Arnathau C., Durand P., Akiana J., Anderson T. J., et al. Multiple independed introductions of Plasmodium falciparum in South America. PNAS. 2012;109(2):511-6. doi: 10.1073/pnas.1119058109.
DOI: 10.1073/pnas.1119058109

Jarcho S. Quinine's Predecessor: Francesco Torti and the Early History of Cinchona. Baltimore, Maryland: Johns Hopkins University Press; 1993.

Поляков В. Е. Открытия Самуэля Ганемана и история зарождения гомеопатии. Педиатрия. Журнал им. Г. Н. Сперанского. 2015;94(4):99-104.

Sappington J., Stith F. The Theory and Treatment of Fevers. Arrow Rock [Mo.]; 1844. Режим доступа: https://historicmissourians.shsmo.org/historicmissourians/name/s/sappington/https://historicmissourians.shsmo.org/historicmissourians/name/s/sappington/

Pelletier P., Caventou J. B. Recherches chimiques sur les quinquinas. Ann. Chim. Phys. 1820;15:289-318.

Dickson D. J.H. On the febrifuge power of the sulphate of quinine. Edinb. Med. Surg. J. 1823;19(77):571-3.

Grove to be sold to bristol-myers. New York Times. Section Business Finance. 1957. P. 35. Режим доступа: https://www.nytimes.com/1957/11/09/archives/grove-to-be-sold-to-bristolmyers-bromoquinine-4way-and-fitch-line.html Режим доступа: https://mycompanies.fandom.com/wiki/Grove_Laboratories https://tennesseeencyclopedia.net/entries/edwin-wiley-grove/https://www.nytimes.com/1957/11/09/archives/grove-to-be-sold-to-bristolmyers-bromoquinine-4way-and-fitch-line.html

Grove to be sold to bristol-myers. New York Times. Section Business Finance. 1957. P. 35. Режим доступа: https://www.nytimes.com/1957/11/09/archives/grove-to-be-sold-to-bristolmyers-bromoquinine-4way-and-fitch-line.html Режим доступа: https://mycompanies.fandom.com/wiki/Grove_Laboratories https://tennesseeencyclopedia.net/entries/edwin-wiley-grove/https://mycompanies.fandom.com/wiki/Grove_Laboratories

Grove to be sold to bristol-myers. New York Times. Section Business Finance. 1957. P. 35. Режим доступа: https://www.nytimes.com/1957/11/09/archives/grove-to-be-sold-to-bristolmyers-bromoquinine-4way-and-fitch-line.html Режим доступа: https://mycompanies.fandom.com/wiki/Grove_Laboratories https://tennesseeencyclopedia.net/entries/edwin-wiley-grove/https://tennesseeencyclopedia.net/entries/edwin-wiley-grove/

Taylor N. Cinchona in Java: the story of quinine. New York: Greenburg; 1945.

Strecker A. Untersuchungenüber die Constitution des Chinins. Liebigs Ann. 1854;1:155-70.

Schulemann W. Synthetic anti-malarial preparations: a discussion of the various steps which led to the synthesis and discovery of «plasmoquine» and a brief account of its use in tropical medicine. Proc. Roy. Soc. Med. 1932;25:897-905.

Горелова Л. Е. Из истории борьбы с малярией. Русский медицинский журнал. 2009;(7):503-4.

Campbell N. A., Reece J. B., Heyden R. «Biology» Seventh edition. Menlo Park,: Addison Wesley Longman, Inc; 2005.

Hückel W. Vorlesungen über Pharmazeutische Chemie und Arzneimittelsynthese, II. Band, Organische Teil. Stuttgart: Enke; 1962.

Guttmann P., Ehrlich P. Über die Wirkung des Methylenblaubei Malaria. Klin. Wochenschr. 1891;28:953-6.

An epitome of current medical literature. Suppl. BMJ. 1892;47.

Funk E., Potter S. L. Potter's therapeutics, materia medica, and pharmacy. Philadelphia: P. Blakiston's Son & Co.; 1917. 733 p.

Kikuth W. Zur Frage der Malaria Prophylaxe. Hoppe Seylers Z. Physiol. Chem. 1942;274:9-18.

Covell G., Nicol W. D. Clinical, chemotherapeutic, and immunological studies on induced malaria. Br. Med. Bull. 1951;8(1):51-5.

Chernin E. The malaria therapy of neurosyphilis. J. Parasitol. 1984;70(5):611-7.

Burrows J. N., Chibale K., Wells T. N.C. The state of the art in anti-malarial drug discovery and development. Curr. Top. Med. Chem. 2011;11:1226-54.

Chopra R. N. Anti-malarial remedies: natural and synthetic. Calcutta Med. J. 1938;34:183-93.

Chopra R. N. Anti-malarial remedies: natural and synthetic. Calcutta Med. J. 1938;34:183-93.

Кнунянц И. Л., Топчиев К. С., Челинцев Г. В. Строение и синтез новых антималярийных веществ. I. Плазмохин. Известия Академии наук СССР. VII серия. Отделение математических и естественных наук. 1934;(1):153-64.

Elderfield R. C., Gensler W. J., Head J. D., Hageman H. A., Kremer C. B., Wright J. B., et al. Alkylaminoalkyl derivatives of 8-aminoquinoline. J. Am. Chem. Soc. 1946;68(8):1524-9.

Mauss H., Mietzsch F. Atebrin, ein neues Heilmittel gegen Malaria. Klin. Wochenschr. 1933;12(33):1276-8.

Mietzsch F. Entwicklungslinien der Chemotherapie (vom chemischen Standpunktgesehen). Klin. Wochenschr. 1951;29(7-8):125-35.

Greenwood D. Conflicts of interest: the genesis of synthetic antimalarial agents in peace and war. J. Antimicrobial Chem. 1995;36:857-72.

Kodak to Sell Drug Unit for $1.68 Billion. Los Angeles Times. June 24, 1994 (accessed 03.05.2013).

Olmos D. German firm to reclaim Bayer aspirin name: drugs: it will acquire Sterling Winthrop's over-the-counter business and recover the rights it lost after WWI. Los Angeles Times. September 14, 1994 (accessed 03.05.2013).

Кнунянц И. Л., Челинцев Г. В., Беневоленская З. В., Осетрова Е. Д., Курсанова А. И. Строение и синтез новых антималярийных веществ. III. Синтез «Атебрина». Известия Академии наук СССР. VII серия. Отделение математических и естественных наук. 1934;(1):165-76.

«Акрихин» - гордость второй пятилетки. Очерки по истории предприятия. Исторический вестник РХТУ. 2016;48:9-14.

Andersag H. Antimalariamittel aus der Gruppehalogensubstitutierter Chinolinverbindungen. Chem. Ber. 1948;81:499-507.

Wiselogle F. Y. A survey of antimalarial drugs, 1941-1945. Ann Arbor: Edwards, 1946: 987 р.

Slater L. B. War and disease: biomedical research on malaria in the twentieth century. New Brunswick, New Jersey: Rutgers University Press; 2009.

Schlitzer M. Malaria chemotherapeutics. Рart I: History of antimalarial drug development, currently used therapeutics, and drugs in clinical development. Chem. Med. Chem. 2007;2:944-86.

Vale N., Moreira R., Gomes P. Primaquine revisited six decades after its discovery. Eur. J. Med. Chem. 2009;44(3):937-53. doi:10.1016/j.ejmech.2008.08.011.
DOI: 10.1016/j.ejmech.2008.08.011

Ashley E. A., Recht J., White N. J. Primaquine: the risks and the benefits. Malar. J. 2014;13:418.

Haston J. C., Hwang J., Tan K. R. Guidance for using tafenoquine for prevention and antirelapse therapy for malaria - United States. Morbid. Mortal. Weekly Rep. 2019;68(46):1062-8. doi: 10.15585/mmwr.mm6846a4.
DOI: 10.15585/mmwr.mm6846a4

Hounkpatin A. B., Kreidenweiss A., Held J. Clinical utility of tafenoquine in the prevention of relapse of Plasmodium vivax malaria: a review on the mode of action and emerging trial data. Infect. Drug Resist. 2019;12:553-70. doi:10.2147/IDR.S151031.
DOI: 10.2147/IDR.S151031

Avina-Zubieta J. A., Galindo-Rodriguez G., Newman S., Suarez-Almazor M. E., Russell A. S. Long term effectiveness of antimalarial drugs in rheumatic diseases. Ann. Rheum. Dis. 1998;57:582-7. doi: 10.1136/ard.57.10.582.
DOI: 10.1136/ard.57.10.582

Quinacrine sterilization: reports on 40,252 cases. Int. J. Gynaecol. Obstet. 2003;83Suppl2:S1-S159.